Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinhuang lozenges
- Development stage
- Unknown
- Lead developer
- Hebei Sams Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Yinhuang lozenges is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Hebei Sams Pharmaceutical. It is primarily indicated for the treatment of upper respiratory tract infections, including acute and chronic tonsillitis, as well as acute and chronic pharyngolaryngitis. The formulation consists of extracts from two key medicinal herbs: Flos Lonicerae (honeysuckle flower) and Radix Scutellariae (skullcap root). The primary active pharmaceutical components are chlorogenic acid (derived from honeysuckle) and baicalin (derived from skullcap), typically maintained in a 1:2 ratio. In TCM terminology, the drug functions through 'heat-clearing and detoxicating' (清热解毒) actions. The lozenge dosage form is specifically designed to allow the active ingredients to maintain prolonged contact with the infected mucosal tissues in the throat, providing localized anti-inflammatory and antimicrobial effects.
- Brand names
- Yinhuang lozenges
- Other names
- 银黄含片Yinhuang Hanpian
Beyond the preview
Go deeper on Yinhuang lozenges.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yinhuang lozenges.